736
CONCLUSION: A possible pharmacokinetic interaction between Dantrolene and Oxybutynin should be borne in mind when considering Carbamazepine medication for a patient with a spinal cord lesion.
 a patient: Subject; Carbamazepine medication: Treatment; a spinal cord lesion: Treatment.Disorder; Dantrolene: Treatment.Drug; Oxybutynin: Treatment.Drug; Carbamazepine: Treatment.Drug; Dantrolene: Combination.Drug; Oxybutynin: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient: Subject; Carbamazepine medication: Treatment; a spinal cord lesion: Treatment.Disorder; Dantrolene: Treatment.Drug; Oxybutynin: Treatment.Drug; Carbamazepine: Treatment.Drug; Dantrolene: Combination.Drug; Oxybutynin: Combination.Drug